Aortic Stenosis and Transcatheter Aortic Valve Implantation: Current Status and Future Directions in Korea
- Author:
Choongki KIM
1
;
Myeong Ki HONG
Author Information
- Publication Type:Review
- From:Korean Circulation Journal 2019;49(4):283-297
- CountryRepublic of Korea
- Language:English
- Abstract: Transcatheter aortic valve implantation (TAVI) has been accepted as one of primary options for treatment of symptomatic severe aortic stenosis. Although TAVI has been predominantly used for patients at high risk or with old age who were not considered optimal candidates for surgical aortic valve replacement (SAVR), its indication is now expanding toward low risk profile and younger age. Many clinical trials are now ongoing to test the possibility of TAVI for use in patients even with uncharted indications who are not eligible for SAVR in current guidelines but may benefit from valve replacement. Current issues including periprocedural safety, long-term adverse events, hemodynamics and durability associated with TAVI should be also solved for expanding use of TAVI. The review presents current status and future directions of TAVI and discusses perspectives in Korea.
